Jump to content

GATC Biotech

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 17:26, 6 October 2018 (History: Journal cites, Added 2 dois to journal cites). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

GATC Biotech AG
Company typeLimited Company
IndustryBiotechnology
Founded1990
HeadquartersKonstanz, Germany
Key people
  • Fritz Pohl, executive chairman
  • Peter Pohl, CEO
  • Marcus Benz, COO
Websitewww.gatc-biotech.com

GATC Biotech is a German company specialist in DNA and RNA sequencing for academic and industrial partners worldwide. The company offers sequencing and bioinformatics solutions from single samples up to large-scale projects. 'The Genome and Diagnostic Centre' focusing on Next and Third Generation sequencing is based in the headquarters in Constance, Germany. The fully automated NGS laboratories are certified under ISO 17025. The Sanger sequencing business is located in 'The European Custom Sequencing Centre' in Cologne, Germany. The proximity to Cologne Bonn Cargo GmbH serves as the logistical hub within Europe.

History

Founded in 1990 the company concentrated in the early days on commercialising a nonradioactive sequencing technology platform,[1] patented by Prof. Pohl one of the founder of GATC. The direct blotting electrophoresis system, the GATC 1500 was utilised in the European Saccharomyces cerevisiae[2] genome project. In 1996 started the transformation from an instrument manufacturer to a service provider in the field of DNA and RNA sequencing. As part of the Gene Alliance, founded in 1998, the company was involved in the large-scale genome analysis project Aspergillus Niger funded by DSM (The Netherlands) and finished in 2001.[3] In 2006 the company started to develop the next generation sequencing business division adding the Europe's first commercial PacBio RS platform in 2011.

Structure of the company

GATC Biotech is a limited company has several subsidiaries in Europe.

  • GATC Biotech AB, Stockholm, Sweden (100%)
  • GATC Biotech Ltd., Cambridge, United Kingdom (100%)
  • GATC Biotech SARL, Marseille, France (100%)

Products

The range of products covers the Sanger sequencing applications[4] as well as next generation sequencing, such as de novo sequencing, human exome sequencing for clinical settings and RNA-Seq.[5]

References

  1. ^ Beck, S; Pohl, FM (1984). "DNA sequencing with direct blotting electrophoresis". EMBO J. 3: 2905–9. doi:10.1002/j.1460-2075.1984.tb02230.x. PMC 557787. PMID 6396083.
  2. ^ Feldmann, H (1994). "Complete DNA sequence of yeast chromosome II". EMBO J. 13: 5795–809. doi:10.1002/j.1460-2075.1994.tb06923.x. PMC 395553. PMID 7813418.
  3. ^ M. M. Ramirez-Corredores (Editor), Abhijeet P. Borole (Editor), 2007, Biocatalysis in Oil Refining, Volume 164 (Studies in Surface Science and Catalysis), ISBN 978-0444522122
  4. ^ Molecular Approaches in Freshwater Ecology
  5. ^ Diversity of research projects